Haemostasis is the process that arrests bleeding from wounds, preventing bl
ood from flowing outside of the vascular bed. Thrombosis is an abnormal con
dition in which the vascular lumen becomes occluded by a mass constituted p
rimarily of aggregated platelets and polymerized fibrin. These thrombi impe
de the normal flow of circulating blood, becoming the acute cause of diseas
es that represent a great health concern in the developed world. Haemostasi
s and thrombosis are two aspects of the same function, ie the biological re
sponse to vascular injury leading to formation of a thrombus, which is plat
elet-rich specifically in the arteries. In either situation, von Willebrand
factor is a crucial participant in the process as its main biological acti
vity is to support platelet adhesion and aggregation in vessels where rapid
blood flow challenges the firm attachment of thrombi to the vascular wall
or exposed extravascular tissues. Advances in understanding the structure a
nd function of von Willebrand factor indicate that this protein, for its un
ique biomechanical properties, may be a potentially useful target of antith
rombotic drugs.